Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 3
2014 1
2015 6
2016 8
2017 13
2018 18
2019 15
2020 4
2021 7
2022 13
2023 10
2024 4
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Adjunctive agents to antipsychotics in schizophrenia: a systematic umbrella review and recommendations for amino acids, hormonal therapies and anti-inflammatory drugs.
Fond G, Mallet J, Urbach M, Benros ME, Berk M, Billeci M, Boyer L, Correll CU, Fornaro M, Kulkarni J, Leboyer M, Llorca PM, Misdrahi D, Rey R, Schürhoff F, Solmi M, Sommer IEC, Stahl SM, Pignon B, Berna F. Fond G, et al. Among authors: urbach m. BMJ Ment Health. 2023 Oct;26(1):e300771. doi: 10.1136/bmjment-2023-300771. BMJ Ment Health. 2023. PMID: 37852631 Free PMC article.
Poverty and inequality in real-world schizophrenia: a national study.
Fond GB, Yon DK, Tran B, Mallet J, Urbach M, Leignier S, Rey R, Misdrahi D, Llorca PM, Schürhoff F, Berna F, Boyer L. Fond GB, et al. Among authors: urbach m. Front Public Health. 2023 Oct 31;11:1182441. doi: 10.3389/fpubh.2023.1182441. eCollection 2023. Front Public Health. 2023. PMID: 38026279 Free PMC article.
Prediction of relapse in a French cohort of outpatients with schizophrenia (FACE-SZ): Prediction, not association.
Barbosa S, Tamouza R, Leboyer M, Aouizerate B, Andrieu C, Andre M, Boukouaci W, Capdevielle D, Chereau I, Kobayashi JC, Coulon N, Dorey JM, Davidovic L, Dubertret C, Fakra E, Fond G, Goze T, Khalfallah O, Leignier S, Llorca PM, Mallet J, Martinuzzi E, Misdrahi D, Oriol N, Pignon B, Rey R, Roux P, Schürhoff F, Schorr B, Urbach M, Very E, Wu CL, Benros M, Simon J, Hasan A; FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) collaborators; Glaichenhaus N, Godin O. Barbosa S, et al. Among authors: urbach m. Prog Neuropsychopharmacol Biol Psychiatry. 2025 Mar 20;137:111304. doi: 10.1016/j.pnpbp.2025.111304. Epub 2025 Feb 27. Prog Neuropsychopharmacol Biol Psychiatry. 2025. PMID: 40023308 Free article.
Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohort.
Fond G, Godin O, Schürhoff F, Berna F, André M, Aouizerate B, Capdevielle D, Chereau I, D' Amato T, Dubertret C, Dubreucq J, Faget C, Lançon C, Leignier S, Mallet J, Misdrahi D, Passerieux C, Pignon B, Rey R, Szoke A, Urbach M, Vidailhet P, Leboyer M, Boyer L, Llorca PM; FACE-SZ group. Fond G, et al. Among authors: urbach m. Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jul 13;101:109927. doi: 10.1016/j.pnpbp.2020.109927. Epub 2020 Mar 12. Prog Neuropsychopharmacol Biol Psychiatry. 2020. PMID: 32173456 Review.
QT Interval, Antipsychotics and Correlates Among Patients with Schizophrenia: Cross-Sectional Data from the Multicentric Real-World FACE-SZ.
Gerentes M, Lajnef M, Szöke A, Aouizerate B, Berna F, Cléry M, Chéreau I, Coulon N, Clauss-Kobayashi J, Fakra E, Dorey JM, Dubertret C, Fond G, Godin O, Goze T, Lançon C, Leboyer M, Leignier S, Llorca PM, Mallet J, Misdrahi D, Oriol N, Rey R, Roux P, Schorr B, Urbach M, Véry E; FACE-SZ (FondaMental Academic Centers of Expertise-Schizophrenia) Group; Schürhoff F, Pignon B. Gerentes M, et al. Among authors: urbach m. Drug Saf. 2025 Jul;48(7):739-752. doi: 10.1007/s40264-025-01526-9. Epub 2025 Mar 15. Drug Saf. 2025. PMID: 40088341
Clinical and inflammatory markers associated with metabolic dysfunction-associated fatty liver disease in a cohort of individuals with chronic schizophrenia (FACE-SZ).
Tokarski R, Barbosa S, Pignon B, Aouizerate B, Andrieu C, Andre M, Boukouaci W, Capdevielle D, Chereau I, Dondé C, Kobayashi JC, Dorey JM, Dubertret C, Fakra E, Fond G, Goze T, Leignier S, Llorca PM, Mallet J, Misdrahi D, Oriol N, Rey R, Roux P, Schürhoff F, Schorr B, Szöke A, Urbach M, Very E, Wu CL; FACE-SZ group; Leboyer M, Tamouza R, Godin O. Tokarski R, et al. Among authors: urbach m. J Psychosom Res. 2025 Aug;195:112192. doi: 10.1016/j.jpsychores.2025.112192. Epub 2025 Jun 22. J Psychosom Res. 2025. PMID: 40561671 Free article.
Pro-inflammatory processes and metabolic syndrome: combined risk of resistance to treatment in patients with schizophrenia from the FACE-SZ cohort.
Saitoh K, Lajnef M, Boukouaci W, Andre M, Andrieu C, Aouizerate B, Barau C, Bouassida J, Capdevielle D, Chereau I, Clauss-Kobayashi J, Coulon N, Dorey JM, Dubertret C, Fakra E, Fond G, Goze T, Le Corvoisier P, Leignier S, Llorca PM, Mallet J, Misdrahi D, Oriol N, Pignon B, Rey R, Roux P, Schürhoff F, Schorr B, Urbach M, Very E, Wu CL; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) collaborators; Leboyer M, Godin O, Tamouza R. Saitoh K, et al. Among authors: urbach m. Psychiatry Res. 2025 Aug;350:116557. doi: 10.1016/j.psychres.2025.116557. Epub 2025 May 20. Psychiatry Res. 2025. PMID: 40460461
Relationships between neuropsychological performance, insight, medication adherence, and social metacognition in schizophrenia.
Roux P, Faivre N, Urbach M, Aouizerate B, Brunel L, Capdevielle D, Chereau I, Dubertret C, Dubreucq J, Fond G, Lançon C, Leignier S, Mallet J, Misdrahi D, Pires S, Schneider P, Schurhoff F, Yazbek H, Zinetti-Bertschy A, Passerieux C, Brunet-Gouet E. Roux P, et al. Among authors: urbach m. Schizophr Res. 2023 Feb;252:48-55. doi: 10.1016/j.schres.2022.12.037. Epub 2023 Jan 7. Schizophr Res. 2023. PMID: 36623435
Handedness as a neurodevelopmental marker in schizophrenia: Results from the FACE-SZ cohort.
Mallet J, Godin O, Le Strat Y, Mazer N, Berna F, Boyer L, Capdevielle D, Clauss J, Chéreau I, D'Amato T, Dubreucq J, Leigner S, Llorca PM, Misdrahi D, Passerieux C, Rey R, Pignon B, Urbach M, Schürhoff F, Fond G, Dubertret C; FACE-SZ (FondaMental Academic Center of Expertise for Schizophrenia Group). Mallet J, et al. Among authors: urbach m. World J Biol Psychiatry. 2022 Sep;23(7):525-536. doi: 10.1080/15622975.2021.2013094. Epub 2021 Dec 17. World J Biol Psychiatry. 2022. PMID: 34918618
3-year incidence and predictors of metabolic syndrome in schizophrenia in the national FACE-SZ cohort.
Godin O, Pignon B, Szoke A, Boyer L, Aouizerate B, Schorr B, André M, Capdevielle D, Chereau I, Coulon N, Dassing R, Dubertret C, Etain B, Leignier S, Llorca PM, Mallet J, Misdrahi D, Passerieux C, Rey R, Urbach M, Schürhoff F, Leboyer M, Fond G. Godin O, et al. Among authors: urbach m. Prog Neuropsychopharmacol Biol Psychiatry. 2023 Jan 10;120:110641. doi: 10.1016/j.pnpbp.2022.110641. Epub 2022 Sep 17. Prog Neuropsychopharmacol Biol Psychiatry. 2023. PMID: 36122839
82 results